Breaking News Instant updates and real-time market news.

BIIB

Biogen

$341.41

-2.67 (-0.78%)

07:38
08/07/18
08/07
07:38
08/07/18
07:38

Biogen resumed with a Buy at Stifel

Stifel analyst Paul Matteis resumed coverage of Biogen with a Buy rating and a $394 price target, citing his above consensus projections for Spinraza in Spinal Muscular Atrophy and his view that the odds of success for Aducanumab in Alzheimer's are "modestly better than 50/50." While there are real reasons to believe "this time is different" with Aducanumab, Matteis does worry that the floor value in a negative scenario for the Alzheimer's drug might be lower than some think, he tells investors.

BIIB Biogen
$341.41

-2.67 (-0.78%)

07/26/18
07/26/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. PIPER CUTS 3D SYSTEMS TO UNDERWEIGHT: Piper Jaffray analyst Troy Jensen downgraded 3D Systems (DDD) to Underweight from Neutral with a $10 price target. He believes competition for the company's main product lines is intensifying. The analyst also thinks 3D will need to increase spending on direct sales, customer support and consulting, meaning "meaningful profitability" will likely be more challenged than revenue growth throughout 2018. He views the stock as overvalued. While Jensen continues to believe the overall 3D printing industry is "growing rapidly," he remains cautious on shares of 3D Systems and Stratasys (SSYS). He reiterated a Neutral rating on the latter. OPCO CUTS E.L.F. TO PERFORM: Oppenheimer analyst Rupesh Parikh downgraded e.l.f. Beauty (ELF) to Perform from Outperform saying the bull case is more uncertain from here. The analyst does not have a price target for the shares. Recent developments, including "still challenging trends" in the mass category and increased tariff uncertainty, bring greater risk to consensus forecasts, Parikh tells investors in a research note. He is harder-pressed to see the case for share outperformance. Ulta Beauty (ULTA) and Estee Lauder (EL) remain Parikh's top picks in beauty. FACEBOOK GETS MULTIPLE DOWNGRADES AFTER Q2 EARNINGS: Nomura Instinet analyst Mark Kelley downgraded Facebook (FB) to Neutral from Buy after the company delivered "underwhelming" Q2 results and guided for revenue growth deceleration through the end of the year. The revenue guidance paired with the expectation for mid-30% operating margins in the medium term or possibly longer means consensus numbers will be cut "drastically," he said. He lowered his price target on Facebook shares to $183 from $228. Facebook was also downgraded to Neutral from Buy by UBS analyst Eric Sheridan, who also lowered his price target for the shares to $180 from $212, and to Outperform from Strong Buy at Raymond James. Facebook shares are down over 19% in late morning trading. PIPER SAYS BIOGEN SELLOFF A BUYING OPPORTUNITY: Biogen (BIIB) shares "will recover and continue to work" into aducanumab's full Phase 3 data in 2020, Piper Jaffray analyst Christopher Raymond told investors. With the stock having run up into these data, the analyst said he understood the "sell-the-news" phenomenon. He believes, however, that the fundamental concerns he's heard from investors "don't seem to hold water." The analyst said to buy Biogen shares on the selloff. He kept an Overweight rating on the name with a $400 price target.
08/01/18
PIPR
08/01/18
NO CHANGE
Target $400
PIPR
Overweight
Piper recommends Biogen shares after meeting with management
After hosting investor meetings with Biogen investor relations this week, Piper Jaffray analyst Christopher Raymond continues to recommend purchase of the shares. The analyst came away feeling like the "all-important" high-dose APOE4 subset analysis of the BAN2401 results "may be provided sooner than later." If shown to have little impact on the overall placebo-adjusted ADCOMS benefit, this should be an important event, Raymond tells investors in a research note. Coupling this with "continued solid commercial momentum and a host of other value-enhancing catalysts," the analyst continues to like the risk/reward on shares of Biogen. He keeps an Overweight rating on the name with a $400 price target.
08/01/18
08/01/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JEFFERIES UPGRADES DROPBOX TO BUY: Jefferies analyst John DiFucci upgraded Dropbox (DBX) to Buy from Hold with an unchanged price target of $32. The analyst is not making a call on the Q2 results, which come on August 9. Rather, the upgrade is based "entirely on valuation," he stated. Dropbox is up 4.7% in late morning trading. JEFFERIES UPGRADES PAPA JOHN'S: Jefferies analyst Alexander Slagle upgraded Papa John's (PZZA) to Buy from Hold and raised his price target for the shares to $58 from $52. The stock, down 50% from highs, now reflects the likelihood that fundamentals will get worse before improving, Slagle said. After reviewing the company's potential path to recovery and possible strategic actions that could create shareholder value, the analyst has a bull case of $75 per share. He thinks this outweighs the bear case, or downside risk, of $35 per share. SAREPTA UPGRADED AFTER PULLBACK: Morgan Stanley analyst Matthew Harrison upgraded Sarepta Therapeutics (SRPT) to Overweight from Equal Weight, noting that the stock has given up much of the gains it saw when its initial DMD gene therapy data was announced. He sees the pullback as an opportunity to own the stock near pre-DMD gene therapy levels without taking the binary risk. He doesn't think a major bear case has emerged on the prospects for the company's DMD gene therapy program and he sees major catalysts in the second half of this year that he believes the market is missing. Harrison has a $163 price target on Sarepta shares. PIPER CUTS SHOPIFY TO NEUTRAL: Piper Jaffray analyst Michael Olson downgraded Shopify (SHOP) to Neutral from Overweight and lowered his price target to $145 from $155, saying that Shopify's Q2 was "good, but not good enough" with monthly recurring revenue below investor expectations. While Olson said Shopify is performing well, he believes their performance is mostly reflected in the stock's current valuation. PIPER RECOMMENDS BIOGEN AFTER MANAGEMENT MEETING: After hosting investor meetings with Biogen (BIIB) investor relations this week, Piper Jaffray analyst Christopher Raymond came away feeling like the "all-important" high-dose APOE4 subset analysis of the BAN2401 results "may be provided sooner than later." If shown to have little impact on the overall placebo-adjusted ADCOMS benefit, this should be an important event, Raymond said. Coupling this with "continued solid commercial momentum and a host of other value-enhancing catalysts," the analyst continues to like the risk/reward on Biogen. He kept an Overweight rating on shares with a $400 price target.

TODAY'S FREE FLY STORIES

INIS

International Isotopes

$0.00

(0.00%)

11:40
11/13/18
11/13
11:40
11/13/18
11:40
Hot Stocks
International Isotopes announces long-term supply agreement for I-131 »

International Isotopes,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$92.96

0.27 (0.29%)

11:40
11/13/18
11/13
11:40
11/13/18
11:40
Options
Repeat call spreads in Procter and Gamble »

Repeat call spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

11:40
11/13/18
11/13
11:40
11/13/18
11:40
General news
U.S. equities have snapped higher »

U.S. equities have…

HXL

Hexcel

$60.93

0.38 (0.63%)

11:38
11/13/18
11/13
11:38
11/13/18
11:38
Conference/Events
Hexcel management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MSFT

Microsoft

$108.43

1.54 (1.44%)

, NLSN

Nielsen

$26.81

0.38 (1.44%)

11:37
11/13/18
11/13
11:37
11/13/18
11:37
Hot Stocks
Microsoft, Nielsen announce strategic alliance for retail innovation »

Nielsen (NLSN) and…

MSFT

Microsoft

$108.43

1.54 (1.44%)

NLSN

Nielsen

$26.81

0.38 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

AAPL

Apple

$196.43

2.275 (1.17%)

11:36
11/13/18
11/13
11:36
11/13/18
11:36
Conference/Events
Apple management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

11:36
11/13/18
11/13
11:36
11/13/18
11:36
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

11:36
11/13/18
11/13
11:36
11/13/18
11:36
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

ABBV

AbbVie

$89.59

-0.11 (-0.12%)

11:34
11/13/18
11/13
11:34
11/13/18
11:34
Hot Stocks
AbbVie says MAVYRET shows high virologic cure rates in treatment-naive HCV »

AbbVie announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$51.75

0.2 (0.39%)

11:32
11/13/18
11/13
11:32
11/13/18
11:32
Hot Stocks
PlayerUnknown's Battlegrounds, coming to PS4 next month »

In a blog posting by Joon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,670.32

33.62 (2.05%)

, GOOG

Alphabet

$1,053.39

14.17 (1.36%)

11:31
11/13/18
11/13
11:31
11/13/18
11:31
Recommendations
Amazon.com, Alphabet, Alphabet Class A analyst commentary  »

Amazon selection of East…

AMZN

Amazon.com

$1,670.32

33.62 (2.05%)

GOOG

Alphabet

$1,053.39

14.17 (1.36%)

GOOGL

Alphabet Class A

$1,062.87

13.27 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

11:30
11/13/18
11/13
11:30
11/13/18
11:30
Conference/Events
Morgan Stanley energy analysts to hold an analyst/industry conference call »

Analysts, along with Ari…

VIAB

Viacom

$32.73

0.15 (0.46%)

11:30
11/13/18
11/13
11:30
11/13/18
11:30
Options
15K Jun 25 - 30 put spreads bought for $1.50 ahead of Viacom's earnings »

15K Jun 25 - 30 put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 04

    Dec

TVPT

Travelport

$15.38

0.39 (2.60%)

11:29
11/13/18
11/13
11:29
11/13/18
11:29
Hot Stocks
Travelport rises after blog report says sale agreement nearing »

Shares of Travelport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,672.00

35.3 (2.16%)

, C

Citi

$65.11

0.88 (1.37%)

11:27
11/13/18
11/13
11:27
11/13/18
11:27
Hot Stocks
Citi to move 1,1000 employees to make room for Amazon in Long Island City Tower »

Citi (C) announced that…

AMZN

Amazon.com

$1,672.00

35.3 (2.16%)

C

Citi

$65.11

0.88 (1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

SFLY

Shutterfly

$57.09

0.18 (0.32%)

11:25
11/13/18
11/13
11:25
11/13/18
11:25
Conference/Events
Shutterfly to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PDD

Pinduoduo

$17.41

0.2 (1.16%)

11:20
11/13/18
11/13
11:20
11/13/18
11:20
Options
Short-term option buyers in Pinduoduo »

Short-term option buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/13/18
11/13
11:17
11/13/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/13/18
11/13
11:16
11/13/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$199.81

10.44 (5.51%)

, BBY

Best Buy

$67.09

-0.05 (-0.07%)

11:15
11/13/18
11/13
11:15
11/13/18
11:15
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

NVDA

Nvidia

$199.81

10.44 (5.51%)

BBY

Best Buy

$67.09

-0.05 (-0.07%)

LITE

Lumentum

$40.77

3.265 (8.71%)

AAPL

Apple

$195.83

1.675 (0.86%)

PRGO

Perrigo

$65.20

-0.34 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 15

    Nov

  • 26

    Nov

  • 10

    Dec

NVDA

Nvidia

$199.69

10.32 (5.45%)

11:15
11/13/18
11/13
11:15
11/13/18
11:15
OnTheFly
Fly Intel: What to watch in Nvidia earnings report »

Nvidia (NVDA) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

  • 10

    Dec

11:15
11/13/18
11/13
11:15
11/13/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
11/13/18
11/13
11:15
11/13/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
11/13/18
11/13
11:15
11/13/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
11/13/18
11/13
11:15
11/13/18
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.